Inventor · disambiguated record
Thomas Brumby
Also filed as: BRUMBY THOMAS
21 granted patents·13 pending applications·196 citations·filing 1989–2025
94Inventor score
Top patents by PatentIndex Score
34 records- 0192US7235561B2Compound and a composition including such a compoundSCHERING AG·Filed 2002·Granted Jun 26, 2007·58 cites·58 claims
- 0289US7598260B2CDK-inhibitory pyrimidines, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2007·Granted Oct 6, 2009·13 cites·79 claims
- 0382US7291624B2CDK-inhibitory pyrimidines, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2004·Granted Nov 6, 2007·16 cites·90 claims
- 0481US12303573B2Formulation of contrast media and process of preparation thereofBAYER AG·Filed 2024·Granted May 20, 2025·0 cites·14 claims
- 0581US8557776B2Compounds and methods for 18F labeled agentsLEHMANN LUTZ·Filed 2007·Granted Oct 15, 2013·14 cites·23 claims
- 0679US7618957B2Perfluoroalkyl-containing complexes, process for their production as well as their useBAYER SCHERING PHARMA AG·Filed 2006·Granted Nov 17, 2009·1 cites·6 claims
- 0778US5547958AN-(8α-ergolinyl)-amidesSCHERING AG·Filed 1994·Granted Aug 20, 1996·17 cites·17 claims
- 0878US5411966A2, 13-disubstituted ergolines, their production and use in pharmaceutical agentsSCHERING AG·Filed 1993·Granted May 2, 1995·22 cites·21 claims
- 0975US9682944B2Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumorsPIRAMAL IMAGING SA·Filed 2014·Granted Jun 20, 2017·3 cites·34 claims
- 1070US11944690B2Formulation of contrast media and process of preparation thereofBAYER AG·Filed 2019·Granted Apr 2, 2024·0 cites·14 claims
- 1169US8784775B2Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumorsLEHMANN LUTZ·Filed 2008·Granted Jul 22, 2014·1 cites·44 claims
- 1267US5158957A2-substituted ergolinesSCHERING AG·Filed 1991·Granted Oct 27, 1992·19 cites·24 claims
- 1366US5212178A8α-acylamino ergolines and use as pharmaceutical agentsSCHERING AG·Filed 1990·Granted May 18, 1993·17 cites·12 claims
- 1464US2025152753A1Formulation of contrast media and process of preparation thereofBAYER AG·Filed 2025·Application pending·0 cites
- 1559US2024156999A1Multimeric chelator compounds for use in targeted radiotherapyBAYER AG·Filed 2022·Application pending·0 cites
- 1659US2010233086A1Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumorsLEHMANN LUTZ·Filed 2008·Application pending·0 cites
- 1759US2004208828A1Enantiomer-pure (4S,8S)- and (4R,8R)-4-p-nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecanedioic acid and derivatives thereof, process for their production and use for the production of pharmaceutical agentsFiled 2004·Application pending·0 cites
- 1857US2024182431A1New contrast agent for use in magnetic resonance imagingBAYER AG·Filed 2022·Application pending·0 cites
- 1956US2009297454A1Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their UseSCHIRMER HEIKO·Filed 2009·Application pending·0 cites
- 2055US10266506B2Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumorsPIRAMAL IMAGING SA·Filed 2017·Granted Apr 23, 2019·0 cites·34 claims
- 2152US2012064002A1Enantiomer-pure (4S,8S)- and (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecanedioic Acid and Derivatives Thereof, Process for their Production and Use for the Production of Pharmaceutical AgentsLEHMANN LUTZ·Filed 2011·Application pending·0 cites
- 2251US5527777APeptide compounds, in particular LHRH-antagonistsSCHERING AG·Filed 1992·Granted Jun 18, 1996·6 cites·8 claims
- 2349US6284779B1Heteroaromatic compoundsSCHERING AKTIIENGESELLSCHAFT·Filed 2000·Granted Sep 4, 2001·1 cites·20 claims
- 2445US2006292079A1Conjugates of hydroxypyridinone derivative metal complexes with biomolecules and their use for MRI diagnosisSCHMITT-WILLICH HERIBERT·Filed 2005·Application pending·0 cites
- 2544US5037832A2-substituted ergolinesSCHERING AG·Filed 1989·Granted Aug 6, 1991·3 cites·27 claims
- 2642US9238631B2Radiolabeled amino acids for diagnostic imagingBERNDT MATHIAS·Filed 2012·Granted Jan 19, 2016·0 cites·28 claims
- 2742US2014309424A1Direct synthesis of 18f-fluoromethoxy compounds for pet imaging and the provision of new precursors for direct radiosynthesis of protected derivatives of o-([18f] fluoromethyl) tyrosineBRUMBY THOMAS·Filed 2012·Application pending·0 cites
- 2842US2022324865A1Substituted dihydropyrazolo pyrazine carboxamide derivativesBAYER AG·Filed 2019·Application pending·0 cites
- 2938US2007003484A1Hydroxypyridinone derivatives, metal complexes thereof and the use thereof for preparing conjugates with biomoleculesSCHMITT-WILLICH HERIBERT·Filed 2005·Application pending·0 cites
- 3036US5219862A8 beta-substituted ergolines, process for their production and their useSCHERING AG·Filed 1990·Granted Jun 15, 1993·2 cites·5 claims
- 3136US2007020183A1Perfluoroalkyl-containing complexes, process for their production as well as their useSCHIRMER HEIKO·Filed 2006·Application pending·0 cites
- 3235US5616573AGlucocorticoidsSCHERING AG·Filed 1994·Granted Apr 1, 1997·3 cites·6 claims
- 3328US10023539B2Aryl-cyanoguanidine compoundsBayer Pharma AG·Filed 2015·Granted Jul 17, 2018·0 cites·14 claims
- 3426US2013149243A1Method for production of f-18 labeled glutamic acid derivativesBERNDT MATHIAS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Brumby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →